Researchers reported that a retinal-image classifier performing near-flawlessly on its home dataset lost accuracy when tested under dataset shift, with probability estimates becoming misaligned with observed outcomes. The work focuses on calibration failures and limited-label recalibration approaches for retinal image classification when data distributions change. The findings matter for clinical AI deployments because a high headline accuracy on one dataset can mask confidence and risk-signaling breakdowns after model distribution drift. The report highlights the need for calibration checks and recalibration strategies tied to new data collections. For biotech and digital health teams, the work provides a concrete example of why post-deployment monitoring must include calibration and not only discrimination metrics. It also reinforces the operational value of domain-shift evaluations in regulatory and real-world performance planning.